Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OYST | Common Stock | Options Exercise | $86.3K | +7.5K | +17.8% | $11.51 | 49.6K | Sep 2, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OYST | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -7.5K | -4.23% | $0.00 | 170K | Sep 2, 2021 | Common Stock | 7.5K | $11.51 | Direct | F1 |
Id | Content |
---|---|
F1 | The Option was granted on July 25, 2019 under the Oyster Point Pharma, Inc. 2016 Equity Incentive Plan. One quarter of the total number of shares subject to the option vested on July 22, 2020, and one forty-eighth of the total number of shares continue to vest monthly thereafter, subject to continued service to the Issuer through each such vesting date. The award is subject to vesting acceleration under certain circumstances. |